Study: Experienced radiation centers have better outcomes for HNC
December 15, 2014 -- Experienced radiation centers have better outcomes for patients with head and neck cancer (HNC), according to a new study in the Journal of Clinical Oncology. Researchers found that patients who underwent radiation therapy at treatment centers with less experience had higher cancer recurrence and poorer overall survival.
Study: HPV vaccine, riskier sexual activity not linked
December 12, 2014 -- The sexual behavior of teenage girls does not appear to be affected after they obtain the human papillomavirus (HPV) vaccine, according to a new study in the Canadian Medical Association Journal.
Antacids linked to better survival in HNSCC
December 11, 2014 -- Patients with head and neck squamous cell carcinoma (HNSCC) who took antacid medicines to control acid reflux had better overall survival in a new study, published in Cancer Prevention Research.
FDA approves Gardasil 9 vaccine for 9 HPV types
December 11, 2014 -- The U.S. Food and Drug Administration (FDA) has approved the Gardasil 9 vaccine for preventing certain diseases caused by nine types of human papillomavirus (HPV).
Vigiliant marks milestone certification
December 11, 2014 -- Vigilant Biosciences has received International Organization for Standardization (ISO) 13485:2003 certification, an internationally recognized quality standard for medical devices.
HPV legislation doesn't increase vaccination among adolescents
November 21, 2014 -- U.S. legislation that requires or encourages young people to get the human papillomavirus (HPV) vaccine has been unsuccessful in getting more of them vaccinated, according to new research presented at the recent American Public Health Association annual meeting.
Global Oral Cancer Forum: An international approach for care, prevention
November 20, 2014 -- The newly formed Global Oral Cancer Forum recruits international participants to share the issues they face; learn about innovations, models, or ideas to curb growing rates of the disease; and help patients who have treatment complications. The group will gather in New York in September 2015, bringing together international multidisciplinary teams that demonstrate passion and dedication to oral cancer.
Lymphoseek earns EU marketing authorization
November 20, 2014 -- Navidea Biopharmaceuticals announced that it has received marketing authorization in the European Union (EU) for its Lymphoseek 250-mcg kit for radiopharmaceutical preparation.
Japanese mushroom may help treat HPV infection
November 13, 2014 -- A Japanese mushroom extract appears to be effective in eradicating human papillomavirus (HPV), according to a pilot clinical trial at the University of Texas Medical School at Houston
Forward Science donates 2nd OralID to Calif. clinic
November 13, 2014 -- Forward Science Technologies, the developers of OralID and CytID, has donated a second OralID device as part of its OralID Facebook Charity Campaign to the Free Clinic of Simi Valley in California.
Special Feature
Aspirin can help battle head/neck cancer

Aspirin appears to offer significant protection against head and neck (HNC) cancer, according to a study in the British Journal of Cancer. Regular aspirin use was associated with a 22% reduction in HNC and seems to be particularly effective in preventing laryngeal cancer. Read more.

VENDOR CONNECT
Dentifrices and Consumer Products
Dry Mouth Products
Tools and Instruments
Oral Cancer Detection
Conferences
Oral Dermatology and Pathology Alaskan Cruise
June 14-21, 2015
Departing Vancouver, British Columbia Canada